Production and immunogenicity of chimaeric human papillomavirus-like particle vaccines
| dc.contributor.advisor | Rybicki, Ed | en_ZA |
| dc.contributor.advisor | Hitzeroth, Inga | en_ZA |
| dc.contributor.author | Burger, Marieta | en_ZA |
| dc.date.accessioned | 2015-02-04T19:14:50Z | |
| dc.date.available | 2015-02-04T19:14:50Z | |
| dc.date.issued | 2010 | en_ZA |
| dc.description | Includes bibliographical references (leaves 129-146). | en_ZA |
| dc.description.abstract | Human papillomavirus (HPV) infection, specifically with oncogenic types, has been implicated in effectively all cervical cancer cases. Cervical cancer is a global health burden, especially in the developing world. Up to 18 types of HPV are considered oncogenic, of which HPV -16 and -18 cause 70% of cervical cancer cases worldwide. Two vaccines are available on the market: Gardasil(R), targeted against HPV -16, -18; -6 and -11, and Cervarix(TM), against -16 and -18. Both vaccines are based on the L1 capsid proteins of the types they are targeted to and are efficient, pro- phylactic, typespecific vaccines. However, two problems remain: they do not protect against nonvaccine types, that may cause a significant proportion of cancers specifically in African and HIV- positive populations, and they cannot be used to treat existing infections. We designed eight different chimaeric vaccines. | en_ZA |
| dc.identifier.apacitation | Burger, M. (2010). <i>Production and immunogenicity of chimaeric human papillomavirus-like particle vaccines</i>. (Thesis). University of Cape Town ,Faculty of Science ,Department of Molecular and Cell Biology. Retrieved from http://hdl.handle.net/11427/12377 | en_ZA |
| dc.identifier.chicagocitation | Burger, Marieta. <i>"Production and immunogenicity of chimaeric human papillomavirus-like particle vaccines."</i> Thesis., University of Cape Town ,Faculty of Science ,Department of Molecular and Cell Biology, 2010. http://hdl.handle.net/11427/12377 | en_ZA |
| dc.identifier.citation | Burger, M. 2010. Production and immunogenicity of chimaeric human papillomavirus-like particle vaccines. University of Cape Town. | en_ZA |
| dc.identifier.ris | TY - Thesis / Dissertation AU - Burger, Marieta AB - Human papillomavirus (HPV) infection, specifically with oncogenic types, has been implicated in effectively all cervical cancer cases. Cervical cancer is a global health burden, especially in the developing world. Up to 18 types of HPV are considered oncogenic, of which HPV -16 and -18 cause 70% of cervical cancer cases worldwide. Two vaccines are available on the market: Gardasil(R), targeted against HPV -16, -18; -6 and -11, and Cervarix(TM), against -16 and -18. Both vaccines are based on the L1 capsid proteins of the types they are targeted to and are efficient, pro- phylactic, typespecific vaccines. However, two problems remain: they do not protect against nonvaccine types, that may cause a significant proportion of cancers specifically in African and HIV- positive populations, and they cannot be used to treat existing infections. We designed eight different chimaeric vaccines. DA - 2010 DB - OpenUCT DP - University of Cape Town LK - https://open.uct.ac.za PB - University of Cape Town PY - 2010 T1 - Production and immunogenicity of chimaeric human papillomavirus-like particle vaccines TI - Production and immunogenicity of chimaeric human papillomavirus-like particle vaccines UR - http://hdl.handle.net/11427/12377 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/12377 | |
| dc.identifier.vancouvercitation | Burger M. Production and immunogenicity of chimaeric human papillomavirus-like particle vaccines. [Thesis]. University of Cape Town ,Faculty of Science ,Department of Molecular and Cell Biology, 2010 [cited yyyy month dd]. Available from: http://hdl.handle.net/11427/12377 | en_ZA |
| dc.language.iso | eng | en_ZA |
| dc.publisher.department | Department of Molecular and Cell Biology | en_ZA |
| dc.publisher.faculty | Faculty of Science | en_ZA |
| dc.publisher.institution | University of Cape Town | |
| dc.subject.other | Molecular and Cell Biology | en_ZA |
| dc.title | Production and immunogenicity of chimaeric human papillomavirus-like particle vaccines | en_ZA |
| dc.type | Master Thesis | |
| dc.type.qualificationlevel | Masters | |
| dc.type.qualificationname | MSc | en_ZA |
| uct.type.filetype | Text | |
| uct.type.filetype | Image | |
| uct.type.publication | Research | en_ZA |
| uct.type.resource | Thesis | en_ZA |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- thesis_sci_2010_burger_m (1).pdf
- Size:
- 17.11 MB
- Format:
- Adobe Portable Document Format
- Description: